In 2012, a study showed that one-third of antimalarial medications in Southeast Asia and Sub-Saharan Africa failed chemical analysis, packaging analysis, or were falsified. 
Mwaka wa 2012, uchunguzi uliofanywa unaonyesha kuwa theluthi ya dawa za Malaria Asia ya Kusini Mashariki na Sahara ndogo ya Afrika zilikuwa na dosari katika uangalizi wa viungo au pakiti au zilikuwa za uongo.